Company: RVRC
Filing Date: 2025-08-13
Form Type: S-1/A
Source: 0001213900-25-075747
Chunk: 198

Company: Revium Rx.
Filing Date: 2025-08-13
Form: S-1/A
Chunk 198
---
 and December 31, 2023, , the Company is not a party
to any litigation that could have a material adverse effect on the Company’s business, financial position, results of operations
or cash flows.

| l. | Basic and diluted loss per share: |

Basic loss
per share is computed by dividing the net loss available to common shareholders by the weighted average number of shares outstanding during
the reporting period. Diluted loss per share is computed similarly to basic loss per share except that the weighted average number of
shares outstanding is increased to include additional shares from the assumed exercise of stock options and warrants, if dilutive. The
average number of shares is calculated by assuming that outstanding conversions were exercised and that the proceeds from such exercises
were used to acquire common shares at the average market price during the reporting period potentially dilutive common shares issuable
upon the exercise of warrants and options were not included in the computation of loss per share because their effect was anti-dilutive

<div align='center'>F-19</div>

REVIUM RX.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (Cont.)

| m. | Share-based payment transactions: |

The Company
accounts for share-based compensation in accordance with ASC 718, “Compensation – Stock Compensation” (“ASC 718”),
which requires companies to estimate the fair value of equity-based payment awards on the date of grant. The value of the portion of the
award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the statements of comprehensive
loss.

The Company
recognizes compensation expenses for the value of its awards granted based on the vesting attribution approach over the requisite service
period of each of the awards, net of estimated forfeitures. Forfeitures are accounted for as they occur. The Company estimates the fair
value of share options granted using the Black-Scholes option pricing model. The option-pricing model requires a number of assumptions,
including the expected share price volatility, free risk interest rate, dividends and the expected option term. Expected volatility was
calculated based on the average of the standard deviation of a sample of similar companies. The expected option term represents the period
that the Company’s share options are expected to be outstanding and is determined based on the simplified method until sufficient
historical exercise data will support using expected life assumptions.

The risk-free
interest rate is based on